Onco-Innovations to Cancel 5.38 Million Shares as Sorbie Unwinds Funding Pact
Published on 11/20/2026 at 18:21 | Editorial boerse-global.deOnco-Innovations has moved a step closer to dismantling its performance-based financing arrangement with the Sorbie entities, unveiling terms that would see millions of shares returned for cancellation and a swath of warrants surrendered — all contingent on approval from Cboe.
The company disclosed on 10 November that it had struck a deal with Sorbie Bornholm LP and Sorbie Investments LLP to terminate the funding agreement between the parties. Under the proposed terms, Sorbie would hand back roughly 5.38 million Onco common shares, which are earmarked for cancellation.
Alongside the share return, Sorbie Investments LLP is set to forfeit 2.25 million additional warrants. The combined steps — the share giveback, the warrant waiver and the relinquishment of payment rights — form the backbone of the planned exit from the performance-linked facility.
Should investors sell immediately? Or is it worth buying Onco-Innovations?
Credit Facility Stays Put as Onco Waives Claims
On the monetary side, Sorbie Bornholm LP is to retain a credit support of CAD$4.444.444. In exchange, Onco-Innovations gives up its rights to further payments tied to that amount. No additional cash outlay is required from Onco under the arrangement, meaning the terms pair Sorbie's retention of the credit support with Onco's waiver of the associated residual claims.
Completion of the whole package hinges on several conditions, with the consent of Cboe — specifically Cboe Canada — standing out as one of the prerequisites.
Shares Advance on the News
Investors greeted the development positively. Onco-Innovations stock climbed 9.3% to €0.1274 in today's trading, building on the prior session's gain of 3.2%, which had left the shares at a closing price of €0.1166 on Thursday.
Ad
Onco-Innovations Stock: New Analysis - 20 November
Fresh Onco-Innovations information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
